You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
*ST中基(000972.SZ):與中國科學院腫瘤與基礎醫學研究所(籌)簽訂戰略合作協議
格隆匯 05-21 18:53

格隆匯5月21日丨*ST中基(000972.SZ)公佈,近日,公司中國科學院腫瘤與基礎醫學研究所(籌)(“甲方”)簽訂了《戰略合作協議》。於《“健康”中國2030規劃綱要》,首次在國家層面提出健康領域中長期戰略規劃,堅持以人民健康為核心,把健康擺在優先發展的戰略地位的要求,甲乙雙方着力發展健康產業,將充分發揮各自的資源優勢,以人民生命健康為目標導向,以科學創新為牽引,以推動基礎研究、應用深化和產業融通為抓手,打造“產學研用”的科創高地,以深入合作推動共同發展,並實現一批研發項目成功完成、產生一系列標誌性成果,在學術研究和經濟效益上攜手共贏,推動健康中國建設。經友好協商,達成戰略合作協議。

中國科學院腫瘤與基礎醫學研究所是中科院首個以腫瘤醫學為主要研究方向的專業研究機構,也是浙江省引進的首個國家級生命健康研究機構。

201958日,浙江省人民政府與中國科學院簽訂醫學合作框架協議,以浙江省腫瘤醫院為依託,共建中國科學院腫瘤與基礎醫學研究所。

根據協議,浙江省人民政府將重點保障中科院腫瘤與基礎醫學研究所機構、編制、建設和運行。中科院將集聚腫瘤與基礎醫學相關研究資源,派駐或協助招聘傑出的醫療和科研專家團隊到浙工作;優先在浙招收研究生,逐步達到200名博士和300名碩士的規模;優先將其在腫瘤相關基礎研究方面取得的科研成果在浙江進行轉化及產業化,並支持推動浙江省生物醫藥、高端製造和生命健康產業升級,不斷帶動科技合作向更廣領域和更高層次邁進。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account